About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sugammadex vs Placebo to Prevent Residual Neuromuscular Block

NCT02728726·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Mayo Clinic

With

Merck Sharp & Dohme LLC
University of Texas
Respiratory Motion, Inc.

Age

18–100

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients undergoing surgery with general anesthesia
Patients weighing \> or = 80 pounds
Patients not intubated prior to surgery
Patients who are able to give informed consent

You may not be if

Patients unable to give informed consent.
Patients whose condition will not allow for placement of the electrode PadSet of ExSpiron
Patients who are anticipated to remain intubated in recovery period.

The record

StatusCompleted

PhasePhase 4

Taking part260

StartedJun 2016

UpdatedJul 14, 2022

Conditions

General Surgery

Where2

Mayo Clinic Florida
Jacksonville, Florida, United States
The University of Texas, UTHealth
Houston, Texas, United States

Clareo Health | Sugammadex vs Placebo to Prevent Residual Neuromuscular Block